NL-OMON26473已完成不适用
Efficacy of addition of hrHPV testing by Hybrid Capture II to conventional cytological screening for cervical cancer.
- Department of Pathology, VU University Medical Center, Amsterdam- SALTRO Artsenlaboratorium & Trombosedienst, Utrecht0 个研究点目标入组 25,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25,000
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Women invited for the cervical cancer screening program (ages 30-60 years);
- •2. General practitioner affiliated with SALTRO laboratory.
排除标准
- •1. Not called for screening, i.e., ages under 30 years, or over 60 years;
- •2. Follow-up of previous non-normal cytology within the current screening round of the program, i.e., abnormal cytology or lesion ¡ÝCIN3 less than 2 years before inclusion;
研究者
相似试验
已完成
不适用
Efficacy of addition of hrHPV testing by Hybrid Capture II to conventional cytological screening for cervical cancer: 5 years follow-up.NL-OMON21745SALTRO - Doctor Laboratory & Thrombosis Service, VU University Medical Center, Department of Pathology50,000
已完成
不适用
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® SpecimensHuman Papilloma Virus InfectionNCT02634190Hologic Deutschland GmbH10,000
Unknown
不适用
HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CINCervical CancerCervical Intraepithelial NeoplasiaNCT01058460The University of Hong Kong12,000
Unknown
不适用
HPV Integration Testing for Cervical Cancer ScreeningCervical CancerCervical Intraepithelial NeoplasiaNCT02576158Huazhong University of Science and Technology12,000
已完成
不适用
Cervical And Self-Sample In Screening StudyCervical CancerIntraepithelial NeoplasiaNCT02397252McGill University1,225